Results 51 to 60 of about 35,087 (150)
Response to 'Pulmonary thrombosis in 2019-nCoV pneumonia?' [PDF]
J Thromb Haemost, 2020 Tang N.
europepmc +4 more sources
In silico identification of vaccine targets for 2019-nCoV [version 2; peer review: 3 approved]
F1000Research, 2020 Background: The newly identified coronavirus known as 2019-nCoV has posed a serious global health threat. According to the latest report (18-February-2020), it has infected more than 72,000 people globally and led to deaths of more than 1,016 people in ...
Chloe H. Lee, Hashem Koohy
doaj +1 more source
Potential treatment methods targeting 2019-nCoV infection
European Journal of Medicinal Chemistry, 2020 The novel coronavirus, 2019-nCoV, has quickly spread across the world and pose serious threat to public health because it can infect people very easily. The major clinical symptoms of 2019-nCoV infection include fever, dry cough, myalgia, fatigue, and diarrhea. The 2019-nCoV belongs to the betacoronavirus family, and gene sequencing results demonstrate
Zheng, Lu +5 more
openaire +4 more sources
In silico identification of vaccine targets for 2019-nCoV [version 1; peer review: 2 approved]
F1000Research, 2020 Background: The newly identified coronavirus known as 2019-nCoV has posed a serious global health threat. According to the latest report (18-February-2020), it has infected more than 72,000 people globally and led to deaths of more than 1,016 people in ...
Chloe Hyun-Jung Lee, Hashem Koohy
doaj +1 more source
Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique
Biology, 2020 In this study, we investigate the infection system of the novel coronavirus (2019-nCoV) with a nonlocal operator defined in the Caputo sense. With the help of the fractional natural decomposition method (FNDM), which is based on the Adomian decomposition
Wei Gao +3 more
doaj +1 more source
Analysis of 4 cases of children with false-positive results of novel coronavirus-specific antibody
BMC Pediatrics, 2022 Background This study attempts to explore the influencing factors and solutions of the colloidal gold method for novel coronavirus (2019-nCoV)-specific IgM/IgG antibody detection, summarize the clinical experience and perfect the examination process ...
Shuzhi Dai +9 more
doaj +1 more source
INFECTION WITH A NOVEL CORONA VIRUS (2019-nCoV) (The PRESENT RISK AND THE CHALLENGE) - (A Brief Review) [PDF]
Basrah Journal of Veterinary Research, 2020 In late December, 2019, patients presenting with suspected of viral pneumonitis due toan non-identified microbial agent were reported in Wuhan, China.
KAMAL ALSAAD
doaj +1 more source
Public Administration, EarlyView.ABSTRACT Regulatory instruments to manage the COVID‐19 pandemic have been the object of rich scholarly debates, primarily focused on early national responses to the crisis. We investigate variation in sub‐national regulatory approaches when a crisis is normalized, its association with competing political ideas about the health‐economy trade‐off and the
Salvador Parrado +3 more
wiley +1 more source
In-silico Immunomodelling of 2019-nCoV [PDF]
, 2020 Abstract Background: Novel Corona Virus 2019 (2019-nCoV) is a positive-sense single-strand RNA virus form coronaviridae family, responsible for corona virus infectious disease 2019 (COVID-19) with rapid transmission. The aim of this study is characterization of major viral proteins, prediction of antigen proteasomal cleavage pattern, MHC class ...
Maali A +4 more
europepmc +2 more sources
Potentially highly potent drugs for 2019-nCoV [PDF]
, 2020 AbstractThe World Health Organization (WHO) has declared the 2019 novel coronavirus (2019-nCoV) infection outbreak a global health emergency. Currently, there is no effective anti-2019-nCoV medication. The sequence identity of the 3CL proteases of 2019-nCoV and SARS is 96%, which provides a sound foundation for structural-based drug repositioning (SBDR)
Nguyen, Duc Duy +4 more
openaire +2 more sources